3SBio Inc. (HKG:1530)
31.62
+1.18 (3.88%)
Nov 26, 2025, 2:35 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 72.82 billion as of November 25, 2025. Its market cap has increased by 434.00% in one year.
Market Cap
72.82B
Enterprise Value
70.67B
Revenue
9.94B
Ranking
n/a
PE Ratio
28.97
Stock Price
31.62
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 72.82B, an increase of 221.24%. That is a compound annual growth rate of 11.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 72.82B | 408.53% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | 17.98B | -29.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 286.49B |
| Hansoh Pharmaceutical Group Company | 241.07B |
| JD Health International | 199.13B |
| Innovent Biologics | 160.75B |
| WuXi Biologics | 130.71B |
| Sino Biopharmaceutical | 124.42B |
| Akeso | 106.85B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.51B |